MRI technologists serving patients who have difficulty understanding English may need to budget additional scanner time—especially when image quality largely depends on patients’ compliance with breathing instructions.

“With increasing global rates of Lyme disease, providing a new option for people to help protect themselves from the disease is more important than ever,” says Annaliesa Anderson, PhD, senior vice president and head of vaccine research & development at Pfizer.

The FDA’s Center for Devices and Radiological Health (CDRH) has updated the status of two previously disaccredited mammography operations, rehabilitating the reputation of one while showing the other in limbo.

The FDA has approved Xoran’s Tron CT system, a full-body fluoroscopy system that is fully mobile, and Viewworks’s Vivix-S F series flat panel detectors for digital radiography.

The commoditization of health data raises questions about who is owed what, and in what proportion, when artificial intelligence renders the data clinically useful and thereby financially profitable.

Radiology business developments that broke softly but may soon make waves: 

Point-of-care MRI is a worthwhile diagnostic option for emergency departments and ICUs concerned about wait or transport times to access fixed MRI for patients with neuroimaging needs.

The differential could signal an increase in patient access, especially in rural areas and the Midwest.